Hear the latest #BTK discussion from esteemed panel Drs. Erik Stilp, Nicolas Mouawad, Liz Genovese, and Kumar Madassery. They share how to optimize #ShockwaveIVL for BTK treatment and talk through their tips & tricks. Watch now: https://lnkd.in/gMyHMbFt US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
Shockwave Medical
Medical Equipment Manufacturing
Santa Clara, California 79,276 followers
Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊
About us
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
- Website
-
http://shockwavemedical.com
External link for Shockwave Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Santa Clara, California
- Type
- Public Company
Locations
-
Primary
5403 Betsy Ross Dr
Santa Clara, California 95054, US
Employees at Shockwave Medical
-
Lori Dossola Lyle
Marketing at Shockwave Medical, Inc.
-
Erika Johnson
-
Bharath Natarajan
Senior Director, Data Platform and Business Intelligence
-
Jason Shields
Sr. Director @ Shockwave Medical | Medical Device | Marketing | Professional Education | Business Development | Digital Surgery | Digital…
Updates
-
International interventionalists, are you curious how the #ShockwaveReducer works? “It’s a story of flow redistribution.” Watch Prof James Spratt’s presentation from #EuroPCR 2024 to get detailed insight into the proposed mechanism of action of the Reducer: https://lnkd.in/g57WXgBJ Want to watch more clips from the EuroPCR 2024 Reducer Symposium? Visit our updated website: https://lnkd.in/g7-UqNsF ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.
-
We factor physician feedback into everything we do, so when we heard you wanted faster pulsing from #ShockwaveL6 our team worked quickly to make it pulse 2X faster. Learn more at https://lnkd.in/gebAh24D US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveIVL
-
ICYMI, the Cardiac Interventions Today Q&A with Dr Robert Riley, lead author of the #SCAI Consensus Statement, tells the creation of the Ca++ algorithm & how he anticipates it will impact clinical practice. Read it here: https://lnkd.in/g6NWM_SH Society for Cardiovascular Angiography & Interventions US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
Eventful two days at the #BCISAHP Annual Conference in Bath, England! Our UK team member Jeffrey Ofori had the opportunity to hold breakout room sessions for nurses and allied professionals on how the #ShockwaveReducer can help treat patients suffering from refractory angina. Special thanks to Kenny Christian from Liverpool Heart and Chest Hospital for his excellent presentation on the implantation procedure and supporting clinical data during the dedicated Reducer session. Learn more about the #Shockwave Coronary Sinus Reducer: https://lnkd.in/g7-UqNsF British Cardiovascular Intervention Society (BCIS) Millbrook Medical Conferences Ltd ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.
-
International physicians, are you curious about the key takeaways from the Reducer-I 6-month results? Watch this Q&A video with Prof Stefan Verheye to find out what the 3-year data could mean in terms of everyday practice for the treatment of patients with refractory angina. Watch the video here: https://lnkd.in/gSV5xfp2 Learn more about the #ShockwaveReducer: https://lnkd.in/g7-UqNsF ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.
-
It’s always a pleasure to welcome Dr Ziad Ali to Europe! In the last few days, Dr Ali visited interventionalists in UK and Italy and discussed #ShockwaveIVL mechanism of action and its benefits when treating hostile coronary calcium. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
Introducing #ReducerReview, our international newsletter covering all things #ShockwaveReducer! Learn about our CE mark, rebranding, and exceptional clinical data from #ACC24. Read about our strong start to 2024 in the first edition, here: https://lnkd.in/gBri_-YA ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.
-
Interested in learning more about the algorithmic approach for #CTOs? On Thursday, June 27th, join Dr Robert Riley at #MLCTO for his talk “Practical Applications of the SCAI Calcified Coronary Lesion Algorithm in Treating CTOs”. US: Rx only. See Important Safety Information: http://bit.ly/3iEq7fC
-
Kudos to Dr Tom Noel, Dr Bill Dixon and the whole team at Tallahassee Memorial Hospital in Florida for enrolling their first patient in the COSIRA II trial! A special thank you to Dr Shmuel Banai for his support in the first randomized, blinded case. To learn more about the COSIRA II trial and the participating sites visit http://clinicaltrials.gov ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.